Symphony Financial, Ltd. Co. Regeneron Pharmaceuticals, Inc. Transaction History

Symphony Financial, Ltd. Co.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	SELL	$544.75 - $658.21 $354,087 - $427,836	-650 Closed	0 $0
Q2 2020 Jul 08, 2020	BUY	$493.32 - $643.92 $95,704 - $124,920	194 Added 42.54%	650 $405,000
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $153,298 - $225,460	456 New	456 $216,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.